6505--PET MRI Radiopharmaceuticals, Detroit
Closed Special Notice Posted
This opportunity was awarded. See its 2 award notices in the notice history.
- Solicitation number
- 36C25026Q1039
- Agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs, Veterans Health Administration, issued a notice of intent to sole source a firm-fixed price purchase order for PET MRI radiopharmaceuticals to Sofie Co. for the John D. Dingell VA Medical Center in Detroit, Michigan, with a response deadline of September 23, 2026. The procurement is restricted to sole source; interested parties may submit capability statements demonstrating clear and convincing evidence that competition would be advantageous to the Government by the deadline.
The one-year purchase order runs October 1, 2026, through September 30, 2027. Required products include Cu-64 Dotatate (Detectnet) at 15 estimated annual doses, F18 PSMA (Pylarify) at 120 doses, F18 Fluorodeoxyglucose (FDG) at 200 doses, and F18 Neuraceq at 20 doses, each measured in 3–10 mCi dose increments. The contractor must furnish products including packaging, transportation, manifests, and reports. The VA's sole source justification rests on a prior sources sought notice (36C25026Q0931) issued August 18–20, 2026, which elicited responses from five contractors. Although other respondents could supply some required products, Sofie Co. alone was capable of providing all specified radiopharmaceuticals. NAICS 325412 (Pharmaceutical Preparation Manufacturing) applies; business size standard is 1,300 employees. Capability statements should be submitted to James Howard, Contract Specialist, james.howard3@va.gov.
Notice text
Special Notice
Page 4 of 4
INTENT TO SOLE SOURCE
The Department of Veterans Affairs, VHA Regional Procurement Office Central, Network Contracting Office 10, intends to enter into a sole source procurement for PET MRI Radiopharmaceuticals for the John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI 48201. The Department of Veterans Affairs intends to award a sole source, firm-fixed price, 1-year purchase order to Sofie Co., 21000 Atlantic Blvd., Suite 730, Dulles, VA 20166. The associated North American Industry Classification System (NAICS) Code is 325412 Pharmaceutical Preparation Manufacturing, and the Business Size Standard is 1,300 employees.
The contractor will furnish (including packaging, transportation, manifests, and reports) all PET radiopharmaceuticals listed below to the John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI 48201 for period of performance October 1, 2026, through September 30, 2027. These are PET radiopharmaceutical supplies used in Nuclear Medicine to perform exams on PET MRI patients.
Product Name
UoM
Est. Annual Quantity
Cu-64 Dotatate (Detectnet) 3-5 mCi
Dose
15
F18 PSMA (Pylarify) 8-10 mCi
Dose
120
F18 Fluorodeoxyglucose (FDG) 8-10 mCi
Dose
200
F18 Neuraceq 8-10 mCi
Dose
20
Pylarify (PSMA) Cancellation Fee
N/A
22
It is the Government s belief that Sofie Co. is the only vendor capable of providing all of these specific radiopharmaceuticals for the Detroit VA. Sources sought notice 36C25026Q0931 was sent out to prospective vendors, with a reply window of August 18, 2026 through August 20, 2026. Responses were received from five contractors, including Sofie Co. Contractor capabilities were reviewed, and although the other contractors could provide some of the required products, Sofie Co. was the only contractor capable of providing all of these specific radiopharmaceuticals required by Detroit VA Nuclear Medicine.
This notice of intent is not a request for competitive proposals or quotes. Interested parties may identify their interest and capability to respond to the requirement. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Interested persons may identify their interests and capability to respond to this requirement no later than 4:00 PM Eastern Time, Wednesday, September 23, 2025. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to meet the subject requirement. This information shall be provided at no cost or obligation to the Government.
Interest/capability statements shall be submitted to James Howard, Contracting Specialist, via e-mail at james.howard3@va.gov. Telephone inquiries will not be accepted.
Files
| File | Type | Posted |
|---|---|---|
| 36C25026Q1039.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--PET MRI Radiopharmaceuticals, Detroit | Award Notice | |
| 6505--PET MRI Radiopharmaceuticals, Detroit | Award Notice | |
| This notice | Special Notice |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity